Capital International Investors 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 6:05 pm Sale | 2024-02-07 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Capital International Investors | 2,819,664 4.000% | -228,518 (-7.50%) | Filing |
| 2023-02-13 3:54 pm Purchase | 2023-02-14 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Capital International Investors | 3,048,182 5.300% | 3,048,182 (New Position) | Filing |